Medicare Enrolled
Dr. Ghiath Yazji, MD
Cardiovascular Disease · Toledo, OH
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yazji from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yazji?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yazji
Dr. Ghiath Yazji is a cardiovascular disease specialist in Toledo, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Yazji performed 4,820 Medicare services across 3,589 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yazji received a total of $5,050 from 46 pharmaceutical and/or device companies across 265 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yazji is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 4% volume in OH
$5,050 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,820
Medicare services
Top 4% in OH for cardiovascular disease
3,589
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~230 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
886 | $10 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
589 | $84 | $208 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
515 | $42 | $121 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
500 | $134 | $431 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
418 | $60 | $142 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
345 | $33 | $495 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
177 | $310 | $915 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
175 | $45 | $146 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
138 | $6 | $31 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
137 | $91 | $205 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
94 | $97 | $270 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
93 | $134 | $361 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $56 | $141 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $128 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
56 | $10 | $29 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
55 | $16 | $44 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
47 | $81 | $228 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $83 | $209 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
43 | $18 | $52 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
42 | $592 | $1,319 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
42 | $23 | $67 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
42 | $28 | $134 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
34 | $126 | $351 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
31 | $88 | $262 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
25 | $59 | $113 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
25 | $9 | $147 |
| Cardiac catheterization | 22 | $200 | $634 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
19 | $82 | $397 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
19 | $42 | $172 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $111 | $320 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
14 | $39 | $74 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
13 | $19 | $51 |
| Heart muscle strain imaging | 12 | $28 | $73 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.4% high complexity
32.2% medium
54.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,050
Total received (2018-2024)
Avg $721/year across 7 years
Top 32% in OH for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
265
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,050 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,474
2023
$946
2022
$664
2021
$355
2020
$91
2019
$885
2018
$635
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$150
Kiniksa Pharmaceuticals International, plc
$148
Penumbra, Inc.
$142
Novartis Pharmaceuticals Corporation
$139
Inari Medical, Inc.
$117
Dexcom, Inc.
$110
Medtronic, Inc.
$91
PFIZER INC.
$89
SI-BONE, INC.
$89
AstraZeneca Pharmaceuticals LP
$84
Boston Scientific Corporation
$61
E.R. Squibb & Sons, L.L.C.
$52
Janssen Pharmaceuticals, Inc
$36
Lexicon Pharmaceuticals, Inc.
$36
Philips North America LLC
$25
Novo Nordisk Inc
$23
Actelion Pharmaceuticals US, Inc.
$21
Alnylam Pharmaceuticals Inc.
$19
Chiesi USA, Inc.
$16
Merck Sharp & Dohme LLC
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 29.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$488
E.R. Squibb & Sons, L.L.C.
$402
PFIZER INC.
$401
Novartis Pharmaceuticals Corporation
$366
Amgen Inc.
$361
Boehringer Ingelheim Pharmaceuticals, Inc.
$299
AstraZeneca Pharmaceuticals LP
$260
SANOFI-AVENTIS U.S. LLC
$148
Kiniksa Pharmaceuticals International, plc
$148
Penumbra, Inc.
$142
Amarin Pharma Inc.
$131
Medtronic Vascular, Inc.
$123
Bayer Healthcare Pharmaceuticals Inc.
$120
Inari Medical, Inc.
$117
Dexcom, Inc.
$110
Gilead Sciences, Inc.
$110
AbbVie Inc.
$107
EKOS Corporation
$102
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$100
Medtronic, Inc.
$91
SI-BONE, INC.
$89
Actelion Pharmaceuticals US, Inc.
$66
Boston Scientific Corporation
$61
Cardiovascular Systems Inc.
$56
Kiniksa Pharmaceuticals, Ltd.
$53
Merck Sharp & Dohme LLC
$52
PORTOLA PHARMACEUTICALS, INC.
$46
BIOTRONIK INC.
$44
ABIOMED
$42
Terumo Medical Corporation
$41
Alnylam Pharmaceuticals Inc.
$40
Lexicon Pharmaceuticals, Inc.
$36
Chiesi USA, Inc.
$34
Merck Sharp & Dohme Corporation
$31
Esperion Therapeutics, Inc.
$27
Philips North America LLC
$25
Edwards Lifesciences Corporation
$25
Daiichi Sankyo Inc.
$23
Novo Nordisk Inc
$23
GENZYME CORPORATION
$23
Impulse Dynamics (USA) Inc.
$19
bsn medical inc
$15
Astellas Pharma US Inc
$14
Pfizer Inc.
$13
Lundbeck LLC
$13
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · ANDEXXA · Arcalyst · BRILINTA · CAMZYOS · CHANTIX · CLEVIPREX · CUTIMED SORBION · ClosureFast · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Dexcom G6 Transmitter · Diamondback Coronary · EKOSONIC · ELIQUIS · ENTRESTO · EVENITY · FABRAZYME · FARXIGA · FLOWTRIEVER CATHETER · INJECTAFER · Impella · Indigo System · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · METACROSS OTW · MULTAQ · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTITORQUE · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · S · SAPIEN 3 Ultra RESILIA · UBRELVY · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
74
Per 100K population
17.3
County median income
$60,095
Nearest hospital
PROMEDICA TOLEDO HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yazji is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 4% in OH), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yazji experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Yazji performed 886 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yazji receive payments from pharmaceutical companies?
Yes. Dr. Yazji received a total of $5,050 from 46 companies across 265 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yazji's costs compare to other cardiologists in Toledo?
Dr. Yazji's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yazji) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Toledo
Browse cardiologists in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in OH
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in OH
Which OH cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology